Current debates in science and technology studies emphasize that the bio-economy—or, the articulation of capitalism and biotechnology—is built on notions of commodity production, commodification, and materiality, emphasizing that it is possible to derive value from body parts, molecular and cellular tissues, biological processes, and so on. What is missing from these perspectives, however, is consideration of the political-economic actors, knowledges, and practices involved in the creation and management of value. As part of a rethinking of value in the bio-economy, this article analyzes three key political-economic processes: financialization, capitalization, and assetization. In doing so, it argues that value is managed as part of a series of valuation practices, it is not inherent in biological materialities.
...More
Article
Daniel Greene;
(2022)
Landlords of the internet: Big data and big real estate
(/isis/citation/CBB116395527/)
Article
Donald Mackenzie;
(April 2017)
A material political economy: Automated Trading Desk and price prediction in high-frequency trading
(/isis/citation/CBB223169333/)
Article
Udo Pesch;
Georgy Ishmaev;
(April 2019)
Fictions and frictions: Promises, transaction costs and the innovation of network technologies: Research Note
(/isis/citation/CBB272675718/)
Article
Kristian Bondo Hansen;
(May 2021)
Model Talk: Calculative Cultures in Quantitative Finance
(/isis/citation/CBB253400044/)
Book
Andrew Flachs;
(2019)
Cultivating Knowledge: Biotechnology, Sustainability, and the Human Cost of Cotton Capitalism in India
(/isis/citation/CBB234890843/)
Book
Amalia Leguizamón;
(2020)
Seeds of power: Environmental injustice and genetically modified soybeans in Argentina
(/isis/citation/CBB173880529/)
Article
Dooren, Thom Van;
(2007)
Terminated Seed: Death, Proprietary Kinship and the Production of (Bio)Wealth
(/isis/citation/CBB000720317/)
Article
Fabrício Monteiro Neves;
(2022)
Some elements of the regime of management of irrelevance in science
(/isis/citation/CBB498387701/)
Article
Poonam Pandey;
Aviram Sharma;
(2017)
NGOs, Controversies, and “Opening Up” of Regulatory Governance of Science in India
(/isis/citation/CBB915250388/)
Article
Alexander Rushforth;
Thomas Franssen;
Sarah de Rijcke;
(2019)
Portfolios of Worth: Capitalizing on Basic and Clinical Problems in Biomedical Research Groups
(/isis/citation/CBB805796865/)
Article
Kelly Moore;
(2021)
Capitalisms, Generative Projects and the New STS
(/isis/citation/CBB341784553/)
Article
Reijer Hendrikse;
Ilke Adriaans;
Tobias J. Klinge;
Rodrigo Fernandez;
(2022)
The Big Techification of Everything
(/isis/citation/CBB019537404/)
Article
Marcelo González Gálvez;
Fernanda Gallegos;
Valentina Turén;
(2021)
Unfinished extinction and the velocities of capitalist sacrifices in the woodlands of central Chile
(/isis/citation/CBB772337866/)
Article
Jonas Rüppel;
Torsten H. Voigt;
(2019)
The Death of the Clinic? Emerging Biotechnologies and the Reconfiguration of Mental Health
(/isis/citation/CBB246876726/)
Book
Charles Lawson;
Berris Charnley;
(2015)
Intellectual Property and Genetically Modified Organisms: A Convergence in Laws
(/isis/citation/CBB742382287/)
Article
Anja Bauer;
Alexander Bogner;
(2020)
Let’s (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues
(/isis/citation/CBB333309152/)
Book
Cong Cao;
(2018)
GMO China: how global debates transformed China's agricultural biotechnology policies
(/isis/citation/CBB647007897/)
Book
John H. Evans;
(2020)
The Human Gene Editing Debate
(/isis/citation/CBB424000521/)
Article
Linsey McGoey;
(March 2017)
The Elusive Rentier Rich: Piketty’s Data Battles and the Power of Absent Evidence
(/isis/citation/CBB574264293/)
Article
Sigrid Vertommen;
Vincenzo Pavone;
Michal Nahman;
(January 2022)
Global Fertility Chains: An Integrative Political Economy Approach to Understanding the Reproductive Bioeconomy
(/isis/citation/CBB344538475/)
Be the first to comment!